Studies Find Low Risk of Thyroid Cancer With GLP-1 Drugs for Diabetes

New research may mitigate concerns that glucagon-like peptide-1 (GLP-1) receptor agonists increase the risk of thyroid cancer, according to 2 recent studies.

Mar 18, 2025 - 16:51
 0
New research may mitigate concerns that glucagon-like peptide-1 (GLP-1) receptor agonists increase the risk of thyroid cancer, according to 2 recent studies.